{
    "card": {
        "schema": "https://ver.cy/schemas/card/1.0.0",
        "id": "vr.tr.ovary-serous-adenocarcinoma",
        "code": "thing-q18556985",
        "url": "https://ver.cy/models/thing/q18556985/",
        "name": "ovary serous adenocarcinoma",
        "alternateNames": [
            "ovarian serous cystadenocarcinoma",
            "high grade ovarian serous adenocarcinoma",
            "low grade ovarian serous adenocarcinoma"
        ],
        "kind": "thing",
        "status": "draft-generated",
        "version": "vr.draft.v3",
        "language": "en",
        "classifiers": {
            "family": "Thing Registry",
            "category": "Cross-cutting context",
            "entryKind": "abstract concept",
            "plane": "XCT",
            "domain": [
                "XCT.STA"
            ],
            "industry": [],
            "navPath": "",
            "tags": [],
            "facets": []
        },
        "whatItIs": "A cross-cutting notion registered under XCT.STA. The registry names it; this draft has not been given a definition yet.",
        "purpose": "Give an agent a durable, checkable way to recognise a ovary serous adenocarcinoma, record what state it is in, and decide what may be done with it.",
        "scope": {
            "in": [],
            "out": [],
            "boundaries": []
        },
        "distinguishingFeatures": [
            "Names folded into this entry, which a task may need to split apart again: ovarian serous cystadenocarcinoma, high grade ovarian serous adenocarcinoma, low grade ovarian serous adenocarcinoma.",
            "3 finer distinctions are held as aliases rather than separate entries, because telling them apart needs a task that asks for it.",
            "Described in 1 Wikipedia languages, which is a measure of how widely the thing is known, not of how important it is."
        ],
        "structure": {
            "bundles": [
                {
                    "id": "identity-and-classification",
                    "name": "Identity, naming and classification",
                    "description": "How an agent tells one ovary serous adenocarcinoma from another, and a ovary serous adenocarcinoma from things that resemble it.",
                    "rationale": "Recognition comes before every other claim. Without stable identity nothing else in the model can be trusted to be about the same thing twice.",
                    "layers": [
                        {
                            "id": "naming-and-identifiers",
                            "name": "Names and identifiers",
                            "description": "The names this thing goes by and the identifiers that survive translation and time.",
                            "findings": [
                                {
                                    "id": "preferred-name-and-aliases",
                                    "name": "Preferred name, aliases and local names",
                                    "description": "Which name to use, which names mean the same thing, and which merely sound similar.",
                                    "questions": [
                                        {
                                            "id": "preferred-name-and-aliases-q01",
                                            "text": "What identifies and describes the name of a ovary serous adenocarcinoma, and in what units or vocabulary?",
                                            "kind": "definition",
                                            "answer_data": [
                                                "identifiers",
                                                "types and classes",
                                                "values with units",
                                                "explicit unknowns"
                                            ]
                                        },
                                        {
                                            "id": "preferred-name-and-aliases-q02",
                                            "text": "Who or what asserted this about the name of a ovary serous adenocarcinoma, by which method, and when was it true?",
                                            "kind": "provenance",
                                            "answer_data": [
                                                "authority",
                                                "method",
                                                "evidence",
                                                "event time",
                                                "knowledge time"
                                            ]
                                        },
                                        {
                                            "id": "preferred-name-and-aliases-q03",
                                            "text": "What may an agent decide or do once the name of a ovary serous adenocarcinoma is known, and what must it refuse?",
                                            "kind": "action",
                                            "answer_data": [
                                                "permitted actions",
                                                "preconditions",
                                                "refusals",
                                                "escalation"
                                            ]
                                        }
                                    ]
                                },
                                {
                                    "id": "stable-identifiers",
                                    "name": "Stable identifiers and external keys",
                                    "description": "Identifiers that keep pointing at this kind of thing across systems and languages.",
                                    "questions": [
                                        {
                                            "id": "stable-identifiers-q01",
                                            "text": "What identifies and describes an identifier for a ovary serous adenocarcinoma, and in what units or vocabulary?",
                                            "kind": "definition",
                                            "answer_data": [
                                                "identifiers",
                                                "types and classes",
                                                "values with units",
                                                "explicit unknowns"
                                            ]
                                        },
                                        {
                                            "id": "stable-identifiers-q02",
                                            "text": "Who or what asserted this about an identifier for a ovary serous adenocarcinoma, by which method, and when was it true?",
                                            "kind": "provenance",
                                            "answer_data": [
                                                "authority",
                                                "method",
                                                "evidence",
                                                "event time",
                                                "knowledge time"
                                            ]
                                        },
                                        {
                                            "id": "stable-identifiers-q03",
                                            "text": "What may an agent decide or do once an identifier for a ovary serous adenocarcinoma is known, and what must it refuse?",
                                            "kind": "action",
                                            "answer_data": [
                                                "permitted actions",
                                                "preconditions",
                                                "refusals",
                                                "escalation"
                                            ]
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "id": "classification-and-granularity",
                            "name": "Classification and granularity",
                            "description": "Where a ovary serous adenocarcinoma sits among kinds, and how finely a task needs to cut it.",
                            "findings": [
                                {
                                    "id": "kind-and-parents",
                                    "name": "Kind, parents and neighbouring kinds",
                                    "description": "The classes this thing belongs to and the ones it is next to.",
                                    "questions": [
                                        {
                                            "id": "kind-and-parents-q01",
                                            "text": "What identifies and describes the kind of a ovary serous adenocarcinoma, and in what units or vocabulary?",
                                            "kind": "definition",
                                            "answer_data": [
                                                "identifiers",
                                                "types and classes",
                                                "values with units",
                                                "explicit unknowns"
                                            ]
                                        },
                                        {
                                            "id": "kind-and-parents-q02",
                                            "text": "Who or what asserted this about the kind of a ovary serous adenocarcinoma, by which method, and when was it true?",
                                            "kind": "provenance",
                                            "answer_data": [
                                                "authority",
                                                "method",
                                                "evidence",
                                                "event time",
                                                "knowledge time"
                                            ]
                                        },
                                        {
                                            "id": "kind-and-parents-q03",
                                            "text": "What may an agent decide or do once the kind of a ovary serous adenocarcinoma is known, and what must it refuse?",
                                            "kind": "action",
                                            "answer_data": [
                                                "permitted actions",
                                                "preconditions",
                                                "refusals",
                                                "escalation"
                                            ]
                                        }
                                    ]
                                },
                                {
                                    "id": "distinguishing-features",
                                    "name": "Distinguishing features",
                                    "description": "What separates a ovary serous adenocarcinoma from the things most often confused with it.",
                                    "questions": [
                                        {
                                            "id": "distinguishing-features-q01",
                                            "text": "What identifies and describes what distinguishes a ovary serous adenocarcinoma, and in what units or vocabulary?",
                                            "kind": "definition",
                                            "answer_data": [
                                                "identifiers",
                                                "types and classes",
                                                "values with units",
                                                "explicit unknowns"
                                            ]
                                        },
                                        {
                                            "id": "distinguishing-features-q02",
                                            "text": "Who or what asserted this about what distinguishes a ovary serous adenocarcinoma, by which method, and when was it true?",
                                            "kind": "provenance",
                                            "answer_data": [
                                                "authority",
                                                "method",
                                                "evidence",
                                                "event time",
                                                "knowledge time"
                                            ]
                                        },
                                        {
                                            "id": "distinguishing-features-q03",
                                            "text": "What may an agent decide or do once what distinguishes a ovary serous adenocarcinoma is known, and what must it refuse?",
                                            "kind": "action",
                                            "answer_data": [
                                                "permitted actions",
                                                "preconditions",
                                                "refusals",
                                                "escalation"
                                            ]
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "id": "state-and-lifecycle",
                    "name": "State and lifecycle",
                    "description": "The states a ovary serous adenocarcinoma passes through and the events that move it between them.",
                    "rationale": "Most decisions about a thing depend on what state it is in now, which is a claim with a time on it, not a property.",
                    "layers": [
                        {
                            "id": "lifecycle-stages",
                            "name": "Lifecycle stages",
                            "description": "From coming into existence to ceasing to be one of these.",
                            "findings": [
                                {
                                    "id": "stages-and-transitions",
                                    "name": "Stages and transitions",
                                    "description": "The stages worth naming and what moves a ovary serous adenocarcinoma between them.",
                                    "questions": [
                                        {
                                            "id": "stages-and-transitions-q01",
                                            "text": "What identifies and describes the lifecycle of a ovary serous adenocarcinoma, and in what units or vocabulary?",
                                            "kind": "definition",
                                            "answer_data": [
                                                "identifiers",
                                                "types and classes",
                                                "values with units",
                                                "explicit unknowns"
                                            ]
                                        },
                                        {
                                            "id": "stages-and-transitions-q02",
                                            "text": "Who or what asserted this about the lifecycle of a ovary serous adenocarcinoma, by which method, and when was it true?",
                                            "kind": "provenance",
                                            "answer_data": [
                                                "authority",
                                                "method",
                                                "evidence",
                                                "event time",
                                                "knowledge time"
                                            ]
                                        },
                                        {
                                            "id": "stages-and-transitions-q03",
                                            "text": "What may an agent decide or do once the lifecycle of a ovary serous adenocarcinoma is known, and what must it refuse?",
                                            "kind": "action",
                                            "answer_data": [
                                                "permitted actions",
                                                "preconditions",
                                                "refusals",
                                                "escalation"
                                            ]
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "id": "observations-and-status",
                            "name": "Observations and current status",
                            "description": "What is observed about a ovary serous adenocarcinoma, how often and by whom.",
                            "findings": [
                                {
                                    "id": "observation-record",
                                    "name": "Observation record",
                                    "description": "How an observation of a ovary serous adenocarcinoma is recorded so that it can be superseded rather than overwritten.",
                                    "questions": [
                                        {
                                            "id": "observation-record-q01",
                                            "text": "What identifies and describes an observation of a ovary serous adenocarcinoma, and in what units or vocabulary?",
                                            "kind": "definition",
                                            "answer_data": [
                                                "identifiers",
                                                "types and classes",
                                                "values with units",
                                                "explicit unknowns"
                                            ]
                                        },
                                        {
                                            "id": "observation-record-q02",
                                            "text": "Who or what asserted this about an observation of a ovary serous adenocarcinoma, by which method, and when was it true?",
                                            "kind": "provenance",
                                            "answer_data": [
                                                "authority",
                                                "method",
                                                "evidence",
                                                "event time",
                                                "knowledge time"
                                            ]
                                        },
                                        {
                                            "id": "observation-record-q03",
                                            "text": "What may an agent decide or do once an observation of a ovary serous adenocarcinoma is known, and what must it refuse?",
                                            "kind": "action",
                                            "answer_data": [
                                                "permitted actions",
                                                "preconditions",
                                                "refusals",
                                                "escalation"
                                            ]
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "id": "definitions-in-contest",
                    "name": "Definitions and who holds them",
                    "description": "What ovary serous adenocarcinoma is taken to mean, and by whom.",
                    "rationale": "When a field disagrees about a concept, the disagreement is the content. A model that picks one definition silently destroys the information.",
                    "layers": [
                        {
                            "id": "competing-definitions",
                            "name": "Competing definitions",
                            "description": "The main readings and the traditions behind them.",
                            "findings": [
                                {
                                    "id": "definition-map",
                                    "name": "Definitions and their holders",
                                    "description": "Each definition with the school or body that holds it.",
                                    "questions": [
                                        {
                                            "id": "definition-map-q01",
                                            "text": "Which definitions of ovary serous adenocarcinoma are in use, and which tradition or body holds each?",
                                            "kind": "definition"
                                        },
                                        {
                                            "id": "definition-map-q02",
                                            "text": "What turns on the difference between them in practice?",
                                            "kind": "boundary"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "id": "operationalisation",
                            "name": "Operationalisation",
                            "description": "How it is measured or applied when it has to be.",
                            "findings": [
                                {
                                    "id": "operational-record",
                                    "name": "Measures and proxies",
                                    "description": "Instruments and indicators used to stand in for it.",
                                    "questions": [
                                        {
                                            "id": "operational-record-q01",
                                            "text": "How is ovary serous adenocarcinoma operationalised or measured in practice, and by what instrument?",
                                            "kind": "measurement"
                                        },
                                        {
                                            "id": "operational-record-q02",
                                            "text": "What does that operationalisation leave out, and when does that matter?",
                                            "kind": "boundary"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "id": "instances-and-use",
                    "name": "Instances, use and consequence",
                    "description": "What counts as an instance of ovary serous adenocarcinoma and what follows from calling something that.",
                    "rationale": "Applying a concept is an act with consequences, so a model must say what the label licenses and what it does not.",
                    "layers": [
                        {
                            "id": "instances",
                            "name": "What counts as an instance",
                            "description": "Clear cases, borderline cases and non-cases.",
                            "findings": [
                                {
                                    "id": "instance-tests",
                                    "name": "Tests for an instance",
                                    "description": "What would settle whether something falls under it.",
                                    "questions": [
                                        {
                                            "id": "instance-tests-q01",
                                            "text": "What would settle whether something is an instance of ovary serous adenocarcinoma?",
                                            "kind": "boundary"
                                        },
                                        {
                                            "id": "instance-tests-q02",
                                            "text": "Which borderline cases are argued about, and on what grounds?",
                                            "kind": "definition"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "id": "consequence",
                            "name": "Consequence of application",
                            "description": "Rights, duties or decisions that follow from the label.",
                            "findings": [
                                {
                                    "id": "consequence-record",
                                    "name": "What the label licenses",
                                    "description": "What an agent may do once something is classified this way.",
                                    "questions": [
                                        {
                                            "id": "consequence-record-q01",
                                            "text": "What follows practically once something is treated as ovary serous adenocarcinoma?",
                                            "kind": "action"
                                        },
                                        {
                                            "id": "consequence-record-q02",
                                            "text": "What must an agent not infer from the label alone?",
                                            "kind": "action"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "id": "provenance-and-evidence",
                    "name": "Provenance, evidence and time",
                    "description": "Where every claim about a ovary serous adenocarcinoma came from and when it held.",
                    "rationale": "A claim without a source and a time cannot be superseded, only overwritten, and an agent that overwrites loses the ability to explain itself.",
                    "layers": [
                        {
                            "id": "source-and-authority",
                            "name": "Source and authority",
                            "description": "Who said it, on what evidence, and how strongly.",
                            "findings": [
                                {
                                    "id": "claim-provenance",
                                    "name": "Claim provenance and confidence",
                                    "description": "The authority behind each claim about a ovary serous adenocarcinoma and how confident it is.",
                                    "questions": [
                                        {
                                            "id": "claim-provenance-q01",
                                            "text": "What identifies and describes a claim about a ovary serous adenocarcinoma, and in what units or vocabulary?",
                                            "kind": "definition",
                                            "answer_data": [
                                                "identifiers",
                                                "types and classes",
                                                "values with units",
                                                "explicit unknowns"
                                            ]
                                        },
                                        {
                                            "id": "claim-provenance-q02",
                                            "text": "Who or what asserted this about a claim about a ovary serous adenocarcinoma, by which method, and when was it true?",
                                            "kind": "provenance",
                                            "answer_data": [
                                                "authority",
                                                "method",
                                                "evidence",
                                                "event time",
                                                "knowledge time"
                                            ]
                                        },
                                        {
                                            "id": "claim-provenance-q03",
                                            "text": "What may an agent decide or do once a claim about a ovary serous adenocarcinoma is known, and what must it refuse?",
                                            "kind": "action",
                                            "answer_data": [
                                                "permitted actions",
                                                "preconditions",
                                                "refusals",
                                                "escalation"
                                            ]
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "id": "time-and-versions",
                            "name": "Time, versions and supersession",
                            "description": "When a claim was true, when it was learnt, and what replaced it.",
                            "findings": [
                                {
                                    "id": "validity-and-supersession",
                                    "name": "Validity period and supersession",
                                    "description": "How an old claim about a ovary serous adenocarcinoma is retired without being erased.",
                                    "questions": [
                                        {
                                            "id": "validity-and-supersession-q01",
                                            "text": "What identifies and describes the validity of a claim about a ovary serous adenocarcinoma, and in what units or vocabulary?",
                                            "kind": "definition",
                                            "answer_data": [
                                                "identifiers",
                                                "types and classes",
                                                "values with units",
                                                "explicit unknowns"
                                            ]
                                        },
                                        {
                                            "id": "validity-and-supersession-q02",
                                            "text": "Who or what asserted this about the validity of a claim about a ovary serous adenocarcinoma, by which method, and when was it true?",
                                            "kind": "provenance",
                                            "answer_data": [
                                                "authority",
                                                "method",
                                                "evidence",
                                                "event time",
                                                "knowledge time"
                                            ]
                                        },
                                        {
                                            "id": "validity-and-supersession-q03",
                                            "text": "What may an agent decide or do once the validity of a claim about a ovary serous adenocarcinoma is known, and what must it refuse?",
                                            "kind": "action",
                                            "answer_data": [
                                                "permitted actions",
                                                "preconditions",
                                                "refusals",
                                                "escalation"
                                            ]
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                }
            ]
        },
        "agentConduct": {
            "may": [
                "observe it, measure it, record its state"
            ],
            "mustNot": [],
            "requiresHuman": []
        },
        "ethics": {
            "considerations": [],
            "affectedParties": []
        },
        "owners": {
            "steward": "",
            "roles": [],
            "masterSystems": []
        },
        "relations": [
            {
                "target": "ovarian serous cystadenocarcinoma",
                "type": "related",
                "note": "covers: Finer kinds folded into this entry because telling them apart needs a task that asks for it. Each is a model waiting to be split out when one does."
            },
            {
                "target": "high grade ovarian serous adenocarcinoma",
                "type": "related",
                "note": "covers: Finer kinds folded into this entry because telling them apart needs a task that asks for it. Each is a model waiting to be split out when one does."
            },
            {
                "target": "low grade ovarian serous adenocarcinoma",
                "type": "related",
                "note": "covers: Finer kinds folded into this entry because telling them apart needs a task that asks for it. Each is a model waiting to be split out when one does."
            }
        ],
        "interaction": {
            "identity": {
                "applicability": "required",
                "items": []
            },
            "properties": {
                "applicability": "not-applicable",
                "items": [
                    "Made of: an abstraction with no physical instance",
                    "Does nothing on its own; everything it does, something else did to it.",
                    "These come from the domain this entry sits in rather than from the entry itself, so treat them as a first guess about the whole domain applied to one thing."
                ]
            },
            "recognition": {
                "applicability": "optional",
                "items": [
                    "Nothing to see. What is recognised is an instance of it, and which instances count is exactly what is argued about."
                ]
            },
            "capabilities": {
                "applicability": "required",
                "items": [
                    "observed and measured"
                ]
            },
            "hazards": {
                "applicability": "required",
                "items": []
            },
            "interfaces": {
                "applicability": "required",
                "items": []
            },
            "context": {
                "applicability": "required",
                "items": [
                    "Described in 1 Wikipedia languages, which measures how widely it is written about rather than how important or how common it is. 3 finer distinctions are held inside this entry as names rather than as separate models."
                ]
            }
        },
        "sources": [],
        "openQuestions": [
            "Which of the bundles below does a real task actually need, and which are ceremony?",
            "What does this thing have that the facets do not capture at all?",
            "Which neighbouring kind is most often confused with a ovary serous adenocarcinoma, and on what evidence are they told apart?",
            "What may an agent decide or do once the name of a ovary serous adenocarcinoma is known, and what must it refuse?",
            "What may an agent decide or do once an identifier for a ovary serous adenocarcinoma is known, and what must it refuse?",
            "What may an agent decide or do once the kind of a ovary serous adenocarcinoma is known, and what must it refuse?"
        ],
        "resources": {
            "spec": "/models/thing/q18556985/?format=json"
        },
        "provenance": {
            "origin": "thing registry, generated draft (pass 1)",
            "builtFrom": [
                "models/draft_model.php",
                "wikidata"
            ],
            "providers": [
                "vr.draft.v3"
            ],
            "researchStatus": "not researched",
            "generatedAt": "",
            "builder": "models/card_draft.php"
        },
        "completeness": {
            "sections": {
                "classifiers": "filled",
                "whatItIs": "derived",
                "purpose": "derived",
                "distinguishingFeatures": "derived",
                "structure": "derived",
                "agentConduct": "derived",
                "ethics": "missing",
                "owners": "missing",
                "relations": "derived",
                "interaction.identity": "missing",
                "interaction.properties": "not-applicable",
                "interaction.recognition": "derived",
                "interaction.capabilities": "derived",
                "interaction.hazards": "missing",
                "interaction.interfaces": "missing",
                "interaction.context": "derived",
                "sources": "missing"
            },
            "notes": {
                "_": "Generated by rule from registry facets. No source was read; every derived section awaits the research pass."
            },
            "score": 0.344
        }
    },
    "model": {
        "rank": 178005,
        "code": "thing-q18556985",
        "model_id": "vr.tr.ovary-serous-adenocarcinoma",
        "name": "ovary serous adenocarcinoma",
        "purpose": "",
        "family": "Thing Registry",
        "category": "Cross-cutting context",
        "status": "draft-generated",
        "kind": "thing",
        "plane": "XCT",
        "domain": "XCT.STA",
        "industry": "",
        "version": "",
        "url": "/models/thing/q18556985/",
        "tier": 2,
        "score": 1,
        "payload": {
            "layer": "wikidata",
            "aliases": [
                "ovarian serous cystadenocarcinoma",
                "high grade ovarian serous adenocarcinoma",
                "low grade ovarian serous adenocarcinoma"
            ],
            "aliasCount": 3,
            "merged": 3,
            "knownIn": 1,
            "facets": null,
            "markers": [],
            "lexicalClass": "",
            "senseRank": null,
            "alsoRegisteredAs": null,
            "source": {
                "dataset": "wikidata",
                "item": "Q18556985",
                "url": "https://www.wikidata.org/wiki/Q18556985",
                "license": "CC0 1.0"
            }
        },
        "draft": {
            "generator": "vr.draft.v3",
            "status": "draft-generated",
            "researched": false,
            "archetype": "abstract concept",
            "method": "Written from the archetype playbook - what this kind of thing needs beyond identity and provenance - and from the structure that recurred across 6,333 models already researched by two engines. Applied to this entry by rule. No source was read for this thing and no claim here is researched. This entry carries no facets of its own, so they were inferred from its domain - a guess about a whole domain applied to one thing.",
            "facetsInferred": true,
            "nextPass": "A researcher replaces this draft with a sourced specification. Treat every sentence below as a proposal to argue with.",
            "purpose": "Give an agent a durable, checkable way to recognise a ovary serous adenocarcinoma, record what state it is in, and decide what may be done with it.",
            "whatItIs": "A cross-cutting notion registered under XCT.STA. The registry names it; this draft has not been given a definition yet.",
            "characteristics": {
                "substance": "abstract",
                "origin": "conceptual",
                "agency": "inert"
            },
            "whatYouCanDoWithIt": [
                "observed and measured"
            ],
            "distinguishingFeatures": [
                "Names folded into this entry, which a task may need to split apart again: ovarian serous cystadenocarcinoma, high grade ovarian serous adenocarcinoma, low grade ovarian serous adenocarcinoma.",
                "3 finer distinctions are held as aliases rather than separate entries, because telling them apart needs a task that asks for it.",
                "Described in 1 Wikipedia languages, which is a measure of how widely the thing is known, not of how important it is."
            ],
            "openQuestionsForResearch": [
                "Which of the bundles below does a real task actually need, and which are ceremony?",
                "What does this thing have that the facets do not capture at all?",
                "Which neighbouring kind is most often confused with a ovary serous adenocarcinoma, and on what evidence are they told apart?"
            ],
            "whatItIsMadeOf": "an abstraction with no physical instance",
            "physicalCharacter": [
                "Does nothing on its own; everything it does, something else did to it.",
                "These come from the domain this entry sits in rather than from the entry itself, so treat them as a first guess about the whole domain applied to one thing."
            ],
            "whatCanBeDoneWithIt": [
                "observe it, measure it, record its state"
            ],
            "howItIsRecognised": [
                "Nothing to see. What is recognised is an instance of it, and which instances count is exactly what is argued about."
            ],
            "relatedModels": [
                {
                    "relation": "covers",
                    "note": "Finer kinds folded into this entry because telling them apart needs a task that asks for it. Each is a model waiting to be split out when one does.",
                    "targets": [
                        "ovarian serous cystadenocarcinoma",
                        "high grade ovarian serous adenocarcinoma",
                        "low grade ovarian serous adenocarcinoma"
                    ]
                }
            ],
            "standing": "Described in 1 Wikipedia languages, which measures how widely it is written about rather than how important or how common it is. 3 finer distinctions are held inside this entry as names rather than as separate models.",
            "structure": {
                "bundles": [
                    {
                        "id": "identity-and-classification",
                        "name": "Identity, naming and classification",
                        "description": "How an agent tells one ovary serous adenocarcinoma from another, and a ovary serous adenocarcinoma from things that resemble it.",
                        "rationale": "Recognition comes before every other claim. Without stable identity nothing else in the model can be trusted to be about the same thing twice.",
                        "layers": [
                            {
                                "id": "naming-and-identifiers",
                                "name": "Names and identifiers",
                                "description": "The names this thing goes by and the identifiers that survive translation and time.",
                                "findings": [
                                    {
                                        "id": "preferred-name-and-aliases",
                                        "name": "Preferred name, aliases and local names",
                                        "description": "Which name to use, which names mean the same thing, and which merely sound similar.",
                                        "questions": [
                                            {
                                                "id": "preferred-name-and-aliases-q01",
                                                "text": "What identifies and describes the name of a ovary serous adenocarcinoma, and in what units or vocabulary?",
                                                "kind": "definition",
                                                "answer_data": [
                                                    "identifiers",
                                                    "types and classes",
                                                    "values with units",
                                                    "explicit unknowns"
                                                ]
                                            },
                                            {
                                                "id": "preferred-name-and-aliases-q02",
                                                "text": "Who or what asserted this about the name of a ovary serous adenocarcinoma, by which method, and when was it true?",
                                                "kind": "provenance",
                                                "answer_data": [
                                                    "authority",
                                                    "method",
                                                    "evidence",
                                                    "event time",
                                                    "knowledge time"
                                                ]
                                            },
                                            {
                                                "id": "preferred-name-and-aliases-q03",
                                                "text": "What may an agent decide or do once the name of a ovary serous adenocarcinoma is known, and what must it refuse?",
                                                "kind": "action",
                                                "answer_data": [
                                                    "permitted actions",
                                                    "preconditions",
                                                    "refusals",
                                                    "escalation"
                                                ]
                                            }
                                        ]
                                    },
                                    {
                                        "id": "stable-identifiers",
                                        "name": "Stable identifiers and external keys",
                                        "description": "Identifiers that keep pointing at this kind of thing across systems and languages.",
                                        "questions": [
                                            {
                                                "id": "stable-identifiers-q01",
                                                "text": "What identifies and describes an identifier for a ovary serous adenocarcinoma, and in what units or vocabulary?",
                                                "kind": "definition",
                                                "answer_data": [
                                                    "identifiers",
                                                    "types and classes",
                                                    "values with units",
                                                    "explicit unknowns"
                                                ]
                                            },
                                            {
                                                "id": "stable-identifiers-q02",
                                                "text": "Who or what asserted this about an identifier for a ovary serous adenocarcinoma, by which method, and when was it true?",
                                                "kind": "provenance",
                                                "answer_data": [
                                                    "authority",
                                                    "method",
                                                    "evidence",
                                                    "event time",
                                                    "knowledge time"
                                                ]
                                            },
                                            {
                                                "id": "stable-identifiers-q03",
                                                "text": "What may an agent decide or do once an identifier for a ovary serous adenocarcinoma is known, and what must it refuse?",
                                                "kind": "action",
                                                "answer_data": [
                                                    "permitted actions",
                                                    "preconditions",
                                                    "refusals",
                                                    "escalation"
                                                ]
                                            }
                                        ]
                                    }
                                ]
                            },
                            {
                                "id": "classification-and-granularity",
                                "name": "Classification and granularity",
                                "description": "Where a ovary serous adenocarcinoma sits among kinds, and how finely a task needs to cut it.",
                                "findings": [
                                    {
                                        "id": "kind-and-parents",
                                        "name": "Kind, parents and neighbouring kinds",
                                        "description": "The classes this thing belongs to and the ones it is next to.",
                                        "questions": [
                                            {
                                                "id": "kind-and-parents-q01",
                                                "text": "What identifies and describes the kind of a ovary serous adenocarcinoma, and in what units or vocabulary?",
                                                "kind": "definition",
                                                "answer_data": [
                                                    "identifiers",
                                                    "types and classes",
                                                    "values with units",
                                                    "explicit unknowns"
                                                ]
                                            },
                                            {
                                                "id": "kind-and-parents-q02",
                                                "text": "Who or what asserted this about the kind of a ovary serous adenocarcinoma, by which method, and when was it true?",
                                                "kind": "provenance",
                                                "answer_data": [
                                                    "authority",
                                                    "method",
                                                    "evidence",
                                                    "event time",
                                                    "knowledge time"
                                                ]
                                            },
                                            {
                                                "id": "kind-and-parents-q03",
                                                "text": "What may an agent decide or do once the kind of a ovary serous adenocarcinoma is known, and what must it refuse?",
                                                "kind": "action",
                                                "answer_data": [
                                                    "permitted actions",
                                                    "preconditions",
                                                    "refusals",
                                                    "escalation"
                                                ]
                                            }
                                        ]
                                    },
                                    {
                                        "id": "distinguishing-features",
                                        "name": "Distinguishing features",
                                        "description": "What separates a ovary serous adenocarcinoma from the things most often confused with it.",
                                        "questions": [
                                            {
                                                "id": "distinguishing-features-q01",
                                                "text": "What identifies and describes what distinguishes a ovary serous adenocarcinoma, and in what units or vocabulary?",
                                                "kind": "definition",
                                                "answer_data": [
                                                    "identifiers",
                                                    "types and classes",
                                                    "values with units",
                                                    "explicit unknowns"
                                                ]
                                            },
                                            {
                                                "id": "distinguishing-features-q02",
                                                "text": "Who or what asserted this about what distinguishes a ovary serous adenocarcinoma, by which method, and when was it true?",
                                                "kind": "provenance",
                                                "answer_data": [
                                                    "authority",
                                                    "method",
                                                    "evidence",
                                                    "event time",
                                                    "knowledge time"
                                                ]
                                            },
                                            {
                                                "id": "distinguishing-features-q03",
                                                "text": "What may an agent decide or do once what distinguishes a ovary serous adenocarcinoma is known, and what must it refuse?",
                                                "kind": "action",
                                                "answer_data": [
                                                    "permitted actions",
                                                    "preconditions",
                                                    "refusals",
                                                    "escalation"
                                                ]
                                            }
                                        ]
                                    }
                                ]
                            }
                        ]
                    },
                    {
                        "id": "state-and-lifecycle",
                        "name": "State and lifecycle",
                        "description": "The states a ovary serous adenocarcinoma passes through and the events that move it between them.",
                        "rationale": "Most decisions about a thing depend on what state it is in now, which is a claim with a time on it, not a property.",
                        "layers": [
                            {
                                "id": "lifecycle-stages",
                                "name": "Lifecycle stages",
                                "description": "From coming into existence to ceasing to be one of these.",
                                "findings": [
                                    {
                                        "id": "stages-and-transitions",
                                        "name": "Stages and transitions",
                                        "description": "The stages worth naming and what moves a ovary serous adenocarcinoma between them.",
                                        "questions": [
                                            {
                                                "id": "stages-and-transitions-q01",
                                                "text": "What identifies and describes the lifecycle of a ovary serous adenocarcinoma, and in what units or vocabulary?",
                                                "kind": "definition",
                                                "answer_data": [
                                                    "identifiers",
                                                    "types and classes",
                                                    "values with units",
                                                    "explicit unknowns"
                                                ]
                                            },
                                            {
                                                "id": "stages-and-transitions-q02",
                                                "text": "Who or what asserted this about the lifecycle of a ovary serous adenocarcinoma, by which method, and when was it true?",
                                                "kind": "provenance",
                                                "answer_data": [
                                                    "authority",
                                                    "method",
                                                    "evidence",
                                                    "event time",
                                                    "knowledge time"
                                                ]
                                            },
                                            {
                                                "id": "stages-and-transitions-q03",
                                                "text": "What may an agent decide or do once the lifecycle of a ovary serous adenocarcinoma is known, and what must it refuse?",
                                                "kind": "action",
                                                "answer_data": [
                                                    "permitted actions",
                                                    "preconditions",
                                                    "refusals",
                                                    "escalation"
                                                ]
                                            }
                                        ]
                                    }
                                ]
                            },
                            {
                                "id": "observations-and-status",
                                "name": "Observations and current status",
                                "description": "What is observed about a ovary serous adenocarcinoma, how often and by whom.",
                                "findings": [
                                    {
                                        "id": "observation-record",
                                        "name": "Observation record",
                                        "description": "How an observation of a ovary serous adenocarcinoma is recorded so that it can be superseded rather than overwritten.",
                                        "questions": [
                                            {
                                                "id": "observation-record-q01",
                                                "text": "What identifies and describes an observation of a ovary serous adenocarcinoma, and in what units or vocabulary?",
                                                "kind": "definition",
                                                "answer_data": [
                                                    "identifiers",
                                                    "types and classes",
                                                    "values with units",
                                                    "explicit unknowns"
                                                ]
                                            },
                                            {
                                                "id": "observation-record-q02",
                                                "text": "Who or what asserted this about an observation of a ovary serous adenocarcinoma, by which method, and when was it true?",
                                                "kind": "provenance",
                                                "answer_data": [
                                                    "authority",
                                                    "method",
                                                    "evidence",
                                                    "event time",
                                                    "knowledge time"
                                                ]
                                            },
                                            {
                                                "id": "observation-record-q03",
                                                "text": "What may an agent decide or do once an observation of a ovary serous adenocarcinoma is known, and what must it refuse?",
                                                "kind": "action",
                                                "answer_data": [
                                                    "permitted actions",
                                                    "preconditions",
                                                    "refusals",
                                                    "escalation"
                                                ]
                                            }
                                        ]
                                    }
                                ]
                            }
                        ]
                    },
                    {
                        "id": "definitions-in-contest",
                        "name": "Definitions and who holds them",
                        "description": "What ovary serous adenocarcinoma is taken to mean, and by whom.",
                        "rationale": "When a field disagrees about a concept, the disagreement is the content. A model that picks one definition silently destroys the information.",
                        "layers": [
                            {
                                "id": "competing-definitions",
                                "name": "Competing definitions",
                                "description": "The main readings and the traditions behind them.",
                                "findings": [
                                    {
                                        "id": "definition-map",
                                        "name": "Definitions and their holders",
                                        "description": "Each definition with the school or body that holds it.",
                                        "questions": [
                                            {
                                                "id": "definition-map-q01",
                                                "text": "Which definitions of ovary serous adenocarcinoma are in use, and which tradition or body holds each?",
                                                "kind": "definition"
                                            },
                                            {
                                                "id": "definition-map-q02",
                                                "text": "What turns on the difference between them in practice?",
                                                "kind": "boundary"
                                            }
                                        ]
                                    }
                                ]
                            },
                            {
                                "id": "operationalisation",
                                "name": "Operationalisation",
                                "description": "How it is measured or applied when it has to be.",
                                "findings": [
                                    {
                                        "id": "operational-record",
                                        "name": "Measures and proxies",
                                        "description": "Instruments and indicators used to stand in for it.",
                                        "questions": [
                                            {
                                                "id": "operational-record-q01",
                                                "text": "How is ovary serous adenocarcinoma operationalised or measured in practice, and by what instrument?",
                                                "kind": "measurement"
                                            },
                                            {
                                                "id": "operational-record-q02",
                                                "text": "What does that operationalisation leave out, and when does that matter?",
                                                "kind": "boundary"
                                            }
                                        ]
                                    }
                                ]
                            }
                        ]
                    },
                    {
                        "id": "instances-and-use",
                        "name": "Instances, use and consequence",
                        "description": "What counts as an instance of ovary serous adenocarcinoma and what follows from calling something that.",
                        "rationale": "Applying a concept is an act with consequences, so a model must say what the label licenses and what it does not.",
                        "layers": [
                            {
                                "id": "instances",
                                "name": "What counts as an instance",
                                "description": "Clear cases, borderline cases and non-cases.",
                                "findings": [
                                    {
                                        "id": "instance-tests",
                                        "name": "Tests for an instance",
                                        "description": "What would settle whether something falls under it.",
                                        "questions": [
                                            {
                                                "id": "instance-tests-q01",
                                                "text": "What would settle whether something is an instance of ovary serous adenocarcinoma?",
                                                "kind": "boundary"
                                            },
                                            {
                                                "id": "instance-tests-q02",
                                                "text": "Which borderline cases are argued about, and on what grounds?",
                                                "kind": "definition"
                                            }
                                        ]
                                    }
                                ]
                            },
                            {
                                "id": "consequence",
                                "name": "Consequence of application",
                                "description": "Rights, duties or decisions that follow from the label.",
                                "findings": [
                                    {
                                        "id": "consequence-record",
                                        "name": "What the label licenses",
                                        "description": "What an agent may do once something is classified this way.",
                                        "questions": [
                                            {
                                                "id": "consequence-record-q01",
                                                "text": "What follows practically once something is treated as ovary serous adenocarcinoma?",
                                                "kind": "action"
                                            },
                                            {
                                                "id": "consequence-record-q02",
                                                "text": "What must an agent not infer from the label alone?",
                                                "kind": "action"
                                            }
                                        ]
                                    }
                                ]
                            }
                        ]
                    },
                    {
                        "id": "provenance-and-evidence",
                        "name": "Provenance, evidence and time",
                        "description": "Where every claim about a ovary serous adenocarcinoma came from and when it held.",
                        "rationale": "A claim without a source and a time cannot be superseded, only overwritten, and an agent that overwrites loses the ability to explain itself.",
                        "layers": [
                            {
                                "id": "source-and-authority",
                                "name": "Source and authority",
                                "description": "Who said it, on what evidence, and how strongly.",
                                "findings": [
                                    {
                                        "id": "claim-provenance",
                                        "name": "Claim provenance and confidence",
                                        "description": "The authority behind each claim about a ovary serous adenocarcinoma and how confident it is.",
                                        "questions": [
                                            {
                                                "id": "claim-provenance-q01",
                                                "text": "What identifies and describes a claim about a ovary serous adenocarcinoma, and in what units or vocabulary?",
                                                "kind": "definition",
                                                "answer_data": [
                                                    "identifiers",
                                                    "types and classes",
                                                    "values with units",
                                                    "explicit unknowns"
                                                ]
                                            },
                                            {
                                                "id": "claim-provenance-q02",
                                                "text": "Who or what asserted this about a claim about a ovary serous adenocarcinoma, by which method, and when was it true?",
                                                "kind": "provenance",
                                                "answer_data": [
                                                    "authority",
                                                    "method",
                                                    "evidence",
                                                    "event time",
                                                    "knowledge time"
                                                ]
                                            },
                                            {
                                                "id": "claim-provenance-q03",
                                                "text": "What may an agent decide or do once a claim about a ovary serous adenocarcinoma is known, and what must it refuse?",
                                                "kind": "action",
                                                "answer_data": [
                                                    "permitted actions",
                                                    "preconditions",
                                                    "refusals",
                                                    "escalation"
                                                ]
                                            }
                                        ]
                                    }
                                ]
                            },
                            {
                                "id": "time-and-versions",
                                "name": "Time, versions and supersession",
                                "description": "When a claim was true, when it was learnt, and what replaced it.",
                                "findings": [
                                    {
                                        "id": "validity-and-supersession",
                                        "name": "Validity period and supersession",
                                        "description": "How an old claim about a ovary serous adenocarcinoma is retired without being erased.",
                                        "questions": [
                                            {
                                                "id": "validity-and-supersession-q01",
                                                "text": "What identifies and describes the validity of a claim about a ovary serous adenocarcinoma, and in what units or vocabulary?",
                                                "kind": "definition",
                                                "answer_data": [
                                                    "identifiers",
                                                    "types and classes",
                                                    "values with units",
                                                    "explicit unknowns"
                                                ]
                                            },
                                            {
                                                "id": "validity-and-supersession-q02",
                                                "text": "Who or what asserted this about the validity of a claim about a ovary serous adenocarcinoma, by which method, and when was it true?",
                                                "kind": "provenance",
                                                "answer_data": [
                                                    "authority",
                                                    "method",
                                                    "evidence",
                                                    "event time",
                                                    "knowledge time"
                                                ]
                                            },
                                            {
                                                "id": "validity-and-supersession-q03",
                                                "text": "What may an agent decide or do once the validity of a claim about a ovary serous adenocarcinoma is known, and what must it refuse?",
                                                "kind": "action",
                                                "answer_data": [
                                                    "permitted actions",
                                                    "preconditions",
                                                    "refusals",
                                                    "escalation"
                                                ]
                                            }
                                        ]
                                    }
                                ]
                            }
                        ]
                    }
                ]
            },
            "statistics": {
                "bundles": 5,
                "layers": 10,
                "findings": 12,
                "questions": 32
            }
        }
    }
}